Core Laboratories (CLB) Gross Profit (2022 - 2026)

Core Laboratories' Gross Profit history runs 5 years deep, the most recent figure standing at $45.7 million for Q1 2026.

• On a quarterly basis, Gross Profit fell 9.73% year-over-year to $45.7 million in Q1 2026; TTM through Mar 2026 was $451.1 million, a 103.79% increase from a year earlier, with the FY2025 full-year figure at $411.1 million, up 81.5% from the prior year.
• Gross Profit fell to $45.7 million in Q1 2026 per CLB's latest filing, from $244.8 million in the prior quarter.
• Across five years, Gross Profit topped out at $244.8 million in Q4 2025 and bottomed at $45.7 million in Q1 2026.
• The 5-year median for Gross Profit is $58.6 million (2022), against an average of $90.9 million.
• Across the five-year window, Gross Profit slumped 74.66% in 2024 and jumped 336.34% in 2025, its largest moves.
• Year by year, Gross Profit stood at $97.4 million in 2022, then soared by 127.3% to $221.4 million in 2023, then slumped by 74.66% to $56.1 million in 2024, then surged by 336.34% to $244.8 million in 2025, then plunged by 81.34% to $45.7 million in 2026.
• Per Business Quant, the three latest CLB Gross Profit figures stand at $45.7 million (Q1 2026), $244.8 million (Q4 2025), and $104.5 million (Q3 2025).